Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

CytoDyn Inc.

OTC: CYDY · Life Sciences · 2 alerts · CIK 1175680

Share price
$0.2502Close, Nov 16
Market cap
$368M
Shares outstanding
1.47BLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All CytoDyn Inc. filings on SEC EDGAR ↗

4:51 PM ET 8-K
Leadership Change

CytoDyn Leadership Change

CytoDyn appointed Robert E. Hoffman as Chief Executive Officer, effective October 20, 2026, succeeding Dr. Jacob Lalezari. Dr. Lalezari resigned from the CEO role but will remain with the company as Head of Research and Translational Sciences. Mr. Hoffman, who previously served as the company's CFO, will also continue to serve as the principal accounting officer.

8:34 AM ET 10-Q
Financial Results

CytoDyn Q1 2026 Results: Net Loss of $19.9M, Loss Widens

CytoDyn reported a net loss of $19.9 million for the quarter ended August 31, 2026, significantly higher than the $5.5 million loss in the prior year due to a $12.3 million loss on note extinguishment. The company continues to express substantial doubt about its ability to continue as a going concern, with an accumulated deficit of $950.4 million.

Key figure
Net loss $19.9M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.